跳至主要内容
临床试验/NCT02141321
NCT02141321已完成2 期

SUB LINGUAL MISOPROSTOL PRIOR TO IUD INSERTION IN WOMEN WITH ONLY PREVIOUS CESARIAN SECTION: A Randomized Controlled Trial

Ain Shams University1 个研究点 分布在 1 个国家目标入组 124 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
124
试验地点
1
主要终点
Pain

研究概览

简要总结

The aim of the work is to evaluate the efficacy of the sub lingual prostaglandin E1 synthetic analogue (misoprostol) before IUD insertion to facilitate the procedure in patients delivered before only by cesarean section.

详细描述

The study will be conducted at Ain Shams University Maternity Hospital. 124 women candidate for Cu T 380A IUD insertion will be enrolled in the study. Half of them will receive 400 micro gram of misoprostol (Sigma) sub lingually and the other half will receive the placebo two hours before IUD insertion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Normal size uterus.
  • Willing to participate.
  • Candidate for IUD insertion.
  • Delivered only by cesarean section.
  • Last delivery is more than 40 days before participating in the study.

排除标准

  • Previous vaginal delivery
  • Signs of genital infection.
  • Menopause.
  • Body mass index (BMI) > 35 kg/m
  • Contraindication to misoprostol.
  • Copper allergy.
  • Positive pregnancy test.
  • Had a prior attempt for IUD insertion.
  • Uterine anomalies.
  • Uterine fibroid.

研究组 & 干预措施

Misoprostol

Experimental

Women will receive two sub lingual tablets each containing 200 micro gram misoprostol (Misotac), receiving a total dose of 400 micro grams. Two hour later, Cu T 380A IUD (PREGNA) will be inserted.

干预措施: Misoprostol (Drug)

Placebo

Placebo Comparator

Women will receive two sub lingual placebo tablets which will be similar in size, color, odor and shape to the misoprostol tablets. Two hour later, Cu T 380A IUD (PREGNA) will be inserted.

干预措施: Placebo (Drug)

结局指标

主要结局

Pain

时间窗: During the procedure

The perception of pain and discomfort as described by the patient assessed by Visual Analogue Scale (VAS). The scale will be graded from 0 to 10, 0 representing no pain at all and 10 worst possible imaginable pain.

次要结局

  • Complications(During the procedure and the following 24 hours.)
  • Difficulty of Procedure(During the procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed S Sweed, MD

Mohamed S. Sweed lecturer of Obstetrics & Gynecology AinShams University.

Ain Shams University

研究点 (1)

Loading locations...

相似试验